NYMOX PHARMACEUTICAL CORPORATION Adjustments For Decrease Increase In Other Assets
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) reported Adjustments For Decrease Increase In Other Assets of $25.00 thousand for the 9-month period ending 2021-09-30, per its 6-K filed 2021-11-12.
Discontinued › Notes
ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets · last filed 2021-11-12
- NYMOX PHARMACEUTICAL CORPORATION adjustments for decrease increase in other assets for the quarter ending 2021-09-30 was -$118.00K.
- NYMOX PHARMACEUTICAL CORPORATION adjustments for decrease increase in other assets for the quarter ending 2020-09-30 was -$145.00K.
| Period end | Adjustments For Decrease Increase In Other Assets 3 month | Adjustments For Decrease Increase In Other Assets 6 month | Adjustments For Decrease Increase In Other Assets 9 month | Adjustments For Decrease Increase In Other Assets 12 month |
|---|---|---|---|---|
| 2021-09-30 | -$118.00K derived: 6-K 9 month − 6-K 6 month · filed 2021-11-12 | $25.00K 6-K · filed 2021-11-12 | ||
| 2021-06-30 | $143.00K 6-K · filed 2021-08-13 | |||
| 2020-09-30 | -$145.00K derived: 6-K 9 month − 6-K 6 month · filed 2021-11-12 | -$167.00K 6-K · filed 2021-11-12 | ||
| 2020-06-30 | -$22.00K 6-K · filed 2021-08-13 | |||
| 2016-12-31 | $271.00K 20-F · filed 2019-03-29 | |||
| 2015-12-31 | $344.00K 20-F · filed 2018-03-30 |